Tevogen (TVGN) Receivables - Other (2023 - 2026)
Tevogen Bio Holdings' (TVGN) quarterly Receivables - Other came in at $158819.0 in Q1 2026, little changed YoY from $158819.0 in Q1 2025, and little changed on a QoQ basis from $158819.0 in Q4 2025.
Tevogen (TVGN) Receivables - Other (2023 - 2026) Analysis & Trends
Tevogen Bio Holdings (TVGN) has 4 years of Receivables - Other data on file, last reported at $158819.0 in Q1 2026.
- Quarterly Receivables - Other changed 0.0% year-over-year to $158819.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $158819.0 (changed 0.0% YoY) and the FY2025 annual result came in at $158819.0, changed 0.0% from the prior year.
- Receivables - Other was little changed at $158819.0 in Q1 2026, from $158819.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $344500.0 in Q4 2023 to a low of $158819.0 in Q1 2024.
- A 4-year average of $177387.1 and a median of $158819.0 in 2024 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2024 — Receivables - Other sank 53.9% — and 2025, when it changed 0.0%.
- Tracing TVGN's Receivables - Other over 4 years: stood at $344500.0 in 2023, then slumped by 53.9% to $158819.0 in 2024, then changed by 0.0% to $158819.0 in 2025, then changed by 0.0% to $158819.0 in 2026.
- The last three Receivables - Other figures came in at $158819.0 (Q1 2026), $158819.0 (Q4 2025), and $158819.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.78 Bn | 131.93 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.59 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.73 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.42 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.19 Bn | 9.80 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - |
| 10 | Tevogen | 26.21 Mn | 26.21 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158,819.00 |
| Jun 30, 2026 | 158,819.00 |
| Mar 31, 2026 | 158,819.00 |
| Mar 31, 2026 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Dec 31, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Sep 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Jun 30, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Mar 31, 2025 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Dec 31, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Sep 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Jun 30, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |
| Mar 31, 2024 | 158,819.00 |